Clinical study of rhIL-11 in prevention and treatment of chemotherapy-induced thrombocytopenia in patients with acute myelogenous leukemia
- VernacularTitle:白细胞介素-11防治急性髓系白血病化疗后血小板减少的临床研究
- Author:
Wenye HUANG
;
Yun ZHANG
;
Jing ZHENG
- Publication Type:Journal Article
- Keywords:
Interleukin-11;
Thrombocytopenia;
Acute myelogenous leukemia
- From:
Cancer Research and Clinic
2001;0(04):-
- CountryChina
- Language:Chinese
-
Abstract:
Objective The current study was designed to observe the efficacy and toxicity of recombinant human interleukin-11 (rhIL-11) in prevention and treatment of chemotherapy-induced thrombocytopenia in patients with acute myelogenous leukemia. Methods The total of 21 acute myelogenous leukemia patients with chemotherapy-induced thrombocytopenia(
